Trial Profile
Niaspan in combination with fluvastatin compared to fluvastatin-monotherapy fpr patients with metabolic syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 May 2011
Price :
$35
*
At a glance
- Drugs Fluvastatin (Primary) ; Niacin (Primary)
- Indications Metabolic syndrome
- Focus Therapeutic Use
- 14 May 2011 New trial record